Evidence map›Paper›PMID 35256607›Full record

ArticleCell death & disease2022

Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog.

Qiang Zhang, Dimitrios-Ilias Balourdas, Bruno Baron, Alon Senitzki, Tali E Haran, Klas G Wiman, Thierry Soussi, Andreas C Joerger

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Mechanistic Insights of a p53-Targeting Small Molecule.ACS pharmacology & translational science · 2025
    Article
  3. TP53: the unluckiest of genes?Cell death and differentiation · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. NAR cancer · 2023
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 6 countries.

Qiang ZhangDepartment of Neuroscience, Biomedicum, Karolinska Institutet, Stockholm, Sweden.
Dimitrios-Ilias BalourdasInstitute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-1790-2268
Bruno BaronPlateforme de Biophysique Moléculaire, Centre de Ressources et de Recherches Technologique (C2RT), Institut Pasteur, 75015, Paris, France.
Alon SenitzkiDepartment of Biology, Technion-Israel Institute of Technology, Technion City, Haifa, 32000, Israel.
Tali E HaranDepartment of Biology, Technion-Israel Institute of Technology, Technion City, Haifa, 32000, Israel. bitali@technion.ac.il.ORCID http://orcid.org/0000-0002-9700-3392
Klas G WimanDepartment of Oncology-Pathology, Bioclinicum, Karolinska Institutet, Stockholm, Sweden. klas.wiman@ki.se.ORCID http://orcid.org/0000-0002-7113-524X
Thierry Soussi *Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. thierry.soussi@sorbonne-universite.fr.ORCID http://orcid.org/0000-0001-8184-3293
Andreas C Joerger *Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438, Frankfurt am Main, Germany. joerger@pharmchem.uni-frankfurt.de.ORCID http://orcid.org/0000-0002-1232-0138
Goethe University Frankfurt · DEKarolinska Institutet · SETechnion – Israel Institute of Technology · ILInstitut Pasteur · FRUppsala University · SE

Funding

Wellcome Trust
6 · The paper itself

Abstract

The extremophile Alvinella pompejana, an annelid worm living on the edge of hydrothermal vents in the Pacific Ocean, is an excellent model system for studying factors that govern protein stability. Low intrinsic stability is a crucial factor for the susceptibility of the transcription factor p53 to inactivating mutations in human cancer. Understanding its molecular basis may facilitate the design of novel therapeutic strategies targeting mutant p53. By analyzing expressed sequence tag (EST) data, we discovered a p53 family gene in A. pompejana. Protein crystallography and biophysical studies showed that it has a p53/p63-like DNA-binding domain (DBD) that is more thermostable than all vertebrate p53 DBDs tested so far, but not as stable as that of human p63. We also identified features associated with its increased thermostability. In addition, the A. pompejana homolog shares DNA-binding properties with human p53 family DBDs, despite its evolutionary distance, consistent with a potential role in maintaining genome integrity. Through extensive structural and phylogenetic analyses, we could further trace key evolutionary events that shaped the structure, stability, and function of the p53 family DBD over time, leading to a potent but vulnerable tumor suppressor in humans.

Indexed as

PolychaetaTumor Suppressor Protein p53AnimalsDNAPhylogenyProtein DomainsDNATumor Suppressor Protein p53

Identifiers

PMID35256607
PMCPMC8901663
OpenAlexW4220757956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.